undamentalytics Newsletter
Sign in

Firefly Neuroscience, Inc. income statement

In fiscal 2025, Firefly Neuroscience, Inc. reported revenue of $1.1m, up 957.4% on the year before, operating income of −$8.9m (a -775.5% margin) and net income of −$19.9m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue7877667119101415120012
Cost of revenue45553458791211——001
Gross profit22222222212433011
Research and development—————————————1212
Selling, general and administrative22222222222686———
Selling and marketing——————————————111
General and administrative——————————————677
Operating income000−0−00−10−0−10−3−5−3−10−9−9
Interest expense——————————0000———
Income before tax000−0−00−10−0−10−2−5−3−10−20−9
Income tax——————————0−110−000
Net income000−0−00−10−0−10−1−18−3−10−20−9
Diluted EPS$0.03$0.00$0.00−$0.00$0.00$0.00−$0.01$0.01$0.00−$0.01$0.01−$0.23————−$0.57
Diluted shares (average)4m4m4m4m4m5m4m5m4m4m5m5m7m13m13m12m16m
EBITDA000−0−00−10−0−10−2−5−3−10−9−9

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AIFF vs ONMDAIFF vs WORXAIFF vs MNDR

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Firefly Neuroscience, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Firefly Neuroscience, Inc.